The transformation-related protein 53 (TRP53) has a canonical role as the ''guardian of the genome,'' serving to protect against the propagation of cells with genomic damage. Autocrine trophic signals act to block the accumulation of TRP53 in the normal preimplantation embryo. Culture of the early embryo at limiting dilutions in simple defined media limits autocrine signaling, resulting in the accumulation of TRP53. This TRP53 reduces the rate of development of embryos. In this study we show that deletion of the Trp53 gene improved development in vitro in a dose-dependent manner. Development to morphological blastocysts increased as the dose of Trp53 was reduced, and this was accompanied by a Trp53-dependent increase in the allocation of cells to the inner cell mass. The intermediate developmental response of heterozygous mice provides evidence for haploinsufficiency of this trait. This haploinsufficiency was evident irrespective of the parent-of-origin of the null allele; however, zygotes with paternal inheritance of the Trp53-null allele had better development in vitro than those with maternal inheritance. There was a beneficial effect of the Trp53-null allele on the number of oocytes released by Trp53 +/À females, and heterozygous males produced higher fertilization rates than controls, although this was independent of the genotype of the fertilizing sperm. The study shows that ovulation induction or culture of embryos in limiting conditions creates conditions that favor the early development of embryos inheriting loss of Trp53 function. This occurs even in the heterozygous state, showing that the conditions provide a potential basis for accelerated accumulation of deleterious mutations within a population. embryo, fertilization, oocyte, p53, sperm
INTRODUCTION
The transformation-related protein 53 (TRP53, also known as P53, and TP53 in humans) plays several critical roles in the function of cells, including a canonical role as the ''guardian of the genome.'' Damage to DNA causes stabilization of the normally labile TRP53 protein. The stable protein acts as a transcription factor, and the resulting transcriptome can act to block cell-cycle progression, enhance DNA repair mechanisms, and induce cellular senescence or cell death by apoptosis [1] [2] [3] . These roles help to ensure that cells with genetic or epigenetic damage do not proliferate, and hence TRP53 acts to maintain the genetic integrity of the organism. Since genomic and epigenomic instability are hallmarks of oncogenesis, these roles of TRP53 in guarding the stability of the genome classify it as an important tumor-suppressor protein. Loss of function to Trp53 (Tp53) predisposes cells to oncogenic transformation, and more than 50% of human cancers have loss of function mutations to TP53. Of these mutations, around 95% occur within the region of the molecule responsible for sequence-specific DNA binding [4] , indicating that its actions in transcription regulation are most important for its tumor-suppressor actions.
Loss-of-function mutations to Trp53 (and many other tumor suppressors) are conventionally considered to be recessive in nature. This means that their effects are only phenotypically expressed in the homozygous state. More detailed analyses of the mouse Trp53 knockout, however, show a phenotype in the hemizygous state (Trp53 þ/À ), with progeny having a higher penetrance of spontaneous tumor formation compared with wild-type sibling progeny [5, 6] . Importantly, the majority of the tumors formed did not show loss of heterozygosity, and this provides direct evidence for haploinsufficiency of the allele in this model [5, 6] . The penetrance of tumor formation was not as great in hemizygous progeny as in homozygous knockouts, showing that haploinsufficiency was not complete. Haploinsufficiency of P53 is also evident in responses of normal cells to exogenous genotoxic stressors such as radiation. The efficiency of the apoptotic or cell block response to radiation exposure of a range of normal somatic cells was partially attenuated in hemizygous cells [7] [8] [9] .
The demonstration of haploinsufficiency of the Trp53-null allele has important implications. Haploinsufficiency can mean that genetic selection (positive or negative) of the allele can occur in the heterozygous state (rather than only the homologous state, as is the case for truly recessive alleles) if the allele results in a difference in the reproductive outcomes. Thus, haploinsufficiency can provide the basis for changes in the incidence of germ line transmission of the allele. Given the much higher incidence of the heterozygous state within a population, haploinsuffiency provides the potential for more profound changes in the population genetics of an allele when acting under selection.
TRP53 is not only responsive to gross genotoxic stress but is also an important regulator of cell survival responses to tropic ligands. In the preimplantation embryo, the activity of transformed mouse 3T3 cell double minute 2 protein (MDM2) is induced by autocrine tropic signaling. This signaling causes phosphatidylinositol-3-kinase-mediated activation of RACalpha serine/threonine-protein kinase (AKT), which in turn phosphorylates and activates MDM2 [10] . MDM2 is a ubiquitin ligase that acts to promote the proteolytic degradation of TRP53, resulting in its maintenance at very low levels within cells [11] . Culture of the early embryo in vitro in simple defined media in limiting dilutions reduces tropic signaling, and in so doing causes the accumulation of TRP53 in sensitive embryos, such as the mouse C57BL/6j strain [10, 12, 13] . This causes reduced rates of development in vitro, and upon transfer of embryos to pseudopregnant recipients they have markedly reduced rates of normal fetal development, and this was significantly ameliorated by the homozygous deletion of Trp53 [12] .
The essential requirement for normal embryo development of the maintenance of TRP53 in a latent state is amply illustrated by the complete embryonic lethality (by the blastocyst stage) caused by the constitutive up-regulation of TRP53 (through the genetic deletion [14] or pharmacological inhibition [10] 
Trp53
À/À embryos, confirming the action of MDM2 in maintaining TRP53 latency [14] .
The reduced development of embryos when TRP53 latency is breached provides a possible point for positive selection for loss of function mutations to Trp53. If the trait is recessive, selection can only occur for Trp53 À/À embryos. Given the haploinsufficiency of some TRP53 functions [5, 6] , it is of considerable interest to determine whether the Trp53-null allele displays haploinsufficiency for embryo development in vitro. To date the roles and regulation of TRP53 in sperm and oocyte function has not been systematically investigated and is, therefore, also of interest to determine whether the Trp53-null allele has any influence on gamete function. In this study we assessed the evidence for haploinsufficiency of the Trp53-null allele on the ability of sperm to fertilize, the ovulation of oocytes, and the development of resulting zygotes in vitro. The study provides evidence for some haploinsufficiency for these traits.
MATERIALS AND METHODS

Animals
The use of animals was in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purpose and was approved by the Institutional Animal Care and Ethics Committee. The strains of mice used in experiments were B6.129S2-Trp53 tm1Tyj strain extensively backcrossed with C57BL/6J (B6). Mating strategies produced Trp53
, and Trp53 þ/þ animals. The genotype of all Trp53 haplotypes was confirmed by PCR prior to use in experiments. All animals were housed and bred in the Gore Hill Research Laboratory, St. Leonards, NSW, Australia, under a 12L:12D cycle and had access to food and water ad libitum. Mature females were superovulated by i.p. injection of 5 IU equine chorionic gonadotropin (Folligon; Intervet International, Boxmeer, The Netherlands) followed 48 h later by 5 IU human chorionic gonadotropin (hCG; Chorulon; Intervet). Females were paired with males of proven fertility. Pregnancy was confirmed by the presence of a copulation plug the following morning (embryo development stage 0.5, E0.5).
Gamete and Embryo Collection and Culture
Oocytes and embryos were flushed from the reproductive tract with Hepesbuffered modified human tubal fluid medium (Hepes-HTF) and cultured in modified HTF (mod-HTF) [15] . All components of the media were tissue culture grade (Sigma Chemical Company, St. Louis, MO) and contained 3 mg bovine serum albumin (BSA) per milliliter (CSL Ltd., Melbourne, VIC, Australia). Zygotes were collected 20-21 h after hCG and freed from their cumulus cells by brief exposure to 300 IU hyaluronidase (Sigma) in Hepes-HTF. Embryos were recovered in minimal volume and assigned to various treatments as required in mod-HTF. Embryos were cultured in 10-ll volumes in 60-well HLA plates (LUX 5260; Nunc, Naperville, IL) overlaid by approximately 2 mm of heavy paraffin oil (Sigma). Culture was at 378C in 5% CO 2 for the periods indicated in individual experiments. Culture of B6 zygotes under these simple defined conditions results in the accumulation of TRP53 in vitro [12, 13] . The development of embryos was assessed after 90 h in culture, and morphology and development stage were reached by each embryo recorded. Cell counts were performed on morphological blastocysts by differentially staining the inner cell mass and trophectoderm populations. This was achieved by incubating for 10 sec in BSA-free Hepes-mod-HTF containing 100 lg/ml propidium iodide (PI; Sigma) and 1% Triton X-100, followed by 1 h in 100% ethanol with 25 lg/ml bisbenzimide at 48C. The outer trophectoderm (TE) cells were stained with both PI and bisbenzimide, the inner cell mass (ICM) only with bisbenzimide. Embryos were then mounted in PBS/glycerol (1:1), and cell counts were performed by epifluorescences microscopy.
Trp53 Genotyping
Whole embryos or 5-mm tail from mice were used for genotyping. Embryos were thoroughly washed three times in PBS and carefully examined to ensure that no contaminating cells were attached. They were then subjected to several rounds of freeze thawing in liquid nitrogen. Tail tissue had DNA extracted using the BuccalAmp DNA Extraction Kit (Epicentre, Madison, WI). DNA was subjected to PCR genotyping. Three primers were used (SigmaGenosys Australia Pty Ltd., Castle Hill, NSW, Australia), including two sense-oriented primers from exon 6 of Trp53 (5 0 AT GAG CCA CCC GAG GTT) and the neomycin gene (5 0 TCC TCG TGC TTT ACG GTA TC) and antisense primer from exon 7 of Trp53 (5 0 TAT ACT CAG AGC CGG CCT). The sensitivity and specificity of the assay for correctly genotyping individual embryos was assessed by examining embryos of known genotype (Trp53
, and Trp53
) and comparing the outcome of the assay with the known genotype. Forty embryos of each genotype were assayed. By genotyping individual embryos of known genotype, the assay was validated as having a sensitivity (successful assay giving a result) of 97.4% and a specificity (giving the correct result) of 95.0%, 92.5%, and 97.5% for Trp53
Statistics
Statistical analyses were performed on SPSS statistical package (version 19; IBM Statistics, Armonk, NY). Changes in the proportion of embryos developing to a given developmental landmark following culture in vitro were assessed by multinomial regression analysis, treating the proportion of zygotes developing to a given developmental landmark as the dependent variable and the treatment and experimental replicate as covariates in the model. The effect of treatment on the number of oocytes released, the fertilization rate, and the cell allocation were assessed using univariate regression analysis within the general linear model. The genetic distribution compared to expected Mendelian segregation was assessed by chi-square analysis.
RESULTS
Mating of Trp53
þ/À females with wild-type males after standard ovulation induction resulted in the release of ;30% more oocytes than corresponding wild-type females (Fig. 1A) . There was no difference in the fertilization rate of the oocytes from Trp53 þ/À compared to wild-type females (Fig. 1B) . The oocytes from heterozygous females produced ;75% more Trp53 þ/À zygotes than Trp53 þ/þ , which was a significant shift from expected Mendelian segregation (Fig. 1C) . If all of the excess oocytes produced by heterozygous females (Fig. 1A) contained the null allele and had an equal likelihood of fertilization, then the dysequilibrium in favor of the heterozygous zygotes would be ;65%. This significant difference (P , 0.001) between the observed and expected distribution of zygotes indicates that (since oocytes from both matings had similar fertilization rates) null oocytes accounted for more than the excess of the released oocytes. This result shows that the absence of a functional Trp53 allele in the oocyte resulted in a higher incidence of ovulation, and the extra Trp53-null oocytes were competent to undergo fertilization.
Oocytes from wild-type females mated with Trp53 þ/À males had a ;20% higher fertilization rate than those resulting from mating with wild-type males (Fig. 2A) . The zygotes resulting from Trp53 þ/À males showed expected Mendelian segregation, indicating that the increased fertilization resulted from increased fertility of sperm from Trp53 þ/À males irrespective of the genotype of individual fertilizing sperm (Fig. 2B) . This result shows a cell nonautonomous role for the Trp53-null allele in the preparation of sperm for successful fertilization, but there was no beneficial effect of the absence of Trp53 in an individual sperm on its competence for fertilization.
The effect of Trp53 gene dosage on the development of embryos in vitro was assessed. Zygotes were cultured at LI ET AL.
limiting dilutions (one zygote cultured individually in 10 ll of media) for 90 h (Fig. 3A) . The morphology of embryos was observed and the stage of development recorded. There was a clear inverse relationship between Trp53 zygosity and the developmental capacity of resultant zygotes. The absence of Trp53 resulted in a higher proportion of embryos developing to morphological blastocysts or blastocysts that commenced to hatch from their zona pellucida, while the presence of functional biallelic Trp53 significantly retarded embryo development and caused more to degenerate. Trp53 þ/À embryos had an intermediate rate of development to the most advanced stages. Analysis of cell numbers in the resulting morphological blastocysts showed that there was no effect of gene dosage on the total number of cells within the blastocysts; however, there was a dose-dependent beneficial effect of the loss of Trp53 on the allocation of cells to the ICM lineage and a reciprocal reduction in allocation to the trophectodermal lineage (Fig. 3B) .
This Trp53 dose-dependent improvement of zygote development in vitro provides evidence for haploinsufficiency of this trait; however, the heterozygosity was achieved by mating Trp53 þ/þ females with Trp53 À/À males. This meant that the Trp53 allele was always inherited from the male line. To assess whether this pattern of inheritance affected the phenotype observed in developing embryos, heterozygosity was also created by mating Trp53 þ/À females with Trp53 þ/þ males or the reciprocal cross. These mating schemes had the advantage of producing sibling embryos of Trp53 þ/À and Trp53
genotype, allowing direct comparison of the effect of genotype on embryo development. The proportion of heterozygous embryos (resulting from either mating cross) that developed to blastocysts and hatching blastocysts was higher than wild-type sibling embryos (Fig. 4) . Interestingly, Trp53 þ/À embryos produced from the Trp53 þ/À males had a better rate of development than those produced by Trp53 þ/À females. A surprising finding was that wild-type embryos produced from the Trp53 þ/þ (female) 3 Trp53 þ/À (male) cross had a better rate of development to morphological blastocysts than the wild-type embryos from the reciprocal cross. This improvement in the wild-type progeny of the Trp53 þ/þ female 3 Trp53 þ/À male cross indicates some cell nonautonomous benefit for early embryo development in vitro resulting from their derivation from Trp53 þ/À males. The effect of Trp53 zygosity on the rate of embryo development in vitro provides evidence for the haploinsufficiency of this developmental trait.
DISCUSSION
This study reports for the first time a rather surprising range of effects of the inheritance of a Trp53-null haplotype when associated with aspects of assisted reproductive technology. We show that the Trp53-null allele effected gamete function (224) females were induced to ovulate and were mated. The number of oocytes released and recovered from the oviduct and the proportion of these that were fertilized was assessed at ;1300 h on E0.5. Embryos were extensively washed to ensure all contaminating cells were removed and then subjected to genotyping by PCR. ***P , 0.001 compared to heterozygous.
FIG. 2. The effect of paternal
Trp53 heterozygosity on (A) fertilization rate, and (B) the genotype of resulting fertilized zygotes resulting from mating of Trp53 heterozygous males. Wild-type (220) or heterozygous (220) males mated with wild-type females, the zygotes recovered from the oviduct, and the proportion fertilized was assessed at ;1300 h on E0.5. Individual embryos were genotyped by PCR. **P , 0.001 compared to heterozygous.
INFLUENCES OF Trp53 ON FERTILITY
and early embryo development in vitro. A cell-autonomous effect was the higher incidence of Trp53-null oocytes after ovulation induction. Fertilization by sperm produced by Trp53 þ/À males was higher than from wild-type males irrespective of the haplotype of the fertilizing sperm. There was a gene-dosage effect on early embryo development in vitro. Homozygous-null embryos were more likely to develop to morphological blastocysts, and the resulting blastocysts had a greater allocation of cells to the inner cell mass than the wildtype embryos. The allocation of cells to the ICM in wild-type embryos was lower than we reported for cultured B6 blastocysts. That paper, however, used cultured embryos in groups (and for a longer period, 96 h) showing the well-known beneficial effect of autocrine tropic ligands [16] influencing the ICM. Heterozygous zygotes developed at a rate that was intermediate between the two homozygous states, providing evidence for partial haploinsufficiency. The study does not reveal whether the strong dose-dependent beneficial effect on the hatching of blastocysts was due to a specific action on the hatching process or simply a reflection of a more advanced developmental state of embryos with reduced TRP53 expression. This point warrants further investigation. Heterozygous zygotes with paternal inheritance of the null allele had better development than those with maternal inheritance of the null allele, yet even wild-type siblings resulting from mating of haploinsufficient males had better development than the wild-type embryos from the reciprocal mating. This study does not reveal whether the better development rate of zygotes with paternally inherited haploinsufficiency (compared with maternal inheritance) was solely due to a combined beneficial effect of the cell autonomous (dependent upon the genotype of the germ cell) and nonautonomous (independent of the genotype of the germ cell) effects.
FIG. 3. The effect of
Trp53 genotype on the rate of development of zygotes cultured in vitro for 90 h. A) Three mating strategies were performed to produce embryos of differing Trp53 dosage (for each cross the genotype of the female is shown first, female 3 male). The resulting zygotes were collected at ;1300 h on E0.5 and cultured individually in 10 ll of media for 90 h. The morphological stage of development reach at this time by each embryo was recorded and then genotyped. Embryos were recorded as having reached the blastocysts stage (Bl), blastocysts that had commenced hatching from their zona pellucida (H Bl), at the morulae stage (Mor), or were retarded at premorula stages or undergoing degeneration (Deg). Statistical analysis by multinomial regression analysis showed that there was a significant effect of gene dosage (P , 0.001) on the rate of development of zygotes. The results are from thred independent replicates, with at least 20 embryos per replicate. B) Morphological blastocysts that developed as a consequence of each cross were stained to allow differential counts of the inner cell mass cells. The figure shows the total cell number of blastocysts from each genotype (whole column) and the number of these cells that were in the inner cell mass compartment (black infill). The results are the mean and SEM of at least 25 blastocysts for each genotype. Statistical analysis was by univariate analysis with least significance test multiple comparisons of multiple means of the ICM count. FIG. 4 . The effect of parent-of-origin of the Trp53-null allele on the development of zygotes in vitro for 90 h. Heterozygous males or females were mated with corresponding wild-type mice, and the resulting zygotes were collected at ;1300 h on E0.5 and cultured individually in 10 ll of media for 90 h (for each cross the genotype of the female is shown first, female 3 male). The morphological stage of development reached at this time point was recorded, and 253 and 364 embryos from Trp53 þ/À and Trp53 þ/þ females, respectively, were genotyped. Embryos were recorded as having reached the blastocysts stage (Bl), blastocysts that had commenced hatching from their zona pellucida (H Bl), at the morula stage (Mor), or were retarded at pre-morula stages or undergoing degeneration (Deg). Multinomial analysis showed that embryos produced by mating Trp53 þ/À females with Trp53 þ/þ males had better rates of development to the blastocysts and hatching blastocysts than embryos from the reciprocal cross. Significant differences from expected Mendelian segregation are shown: *P , 0.05, **P , 0.01.
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The cell nonautonomous effect of paternal haploinsufficiency on fertilization and early embryo development in vitro suggests that some feature of the male reproductive tract function was modified in a manner that favored the fertilizing capacity of the resultant sperm. TRP53 activates canonical stress response pathways in most somatic cells, and similar actions within the male reproductive tract are likely to occur. As an example, testicular and male reproductive tract function are known to be particularly susceptible to oxidative stress [17] , and TRP53 is an important affector of oxidative stress responses [18] . In the mouse, Trp53-null mice have better sperm quality than wild types [19] . A decrease in the number of double-strand breaks within sperm, possibly due to an elevated degree of DNA cross-linking, was associated with reduced Trp53 gene dosage [20] .
A specific requirement for Trp53 in oogenesis and follicular maturation has not been defined. Extensive germ cell programmed death occurs during oogeneisis and, although this is reduced in Bcl-x-or Bcl-2-deficient mice (antiapoptotic genes), no definitive essential role for Trp53 has been identified [21, 22] . Further analysis is required to define whether the increased ovulation of Trp53-null oocytes from Trp53 þ/À females is due to differences in germ cell allocation, folliculogenesis, or ovulation.
Even though heterozygous embryos from Trp53
þ/À (male) mating had a better development rate than those from the reciprocal cross, their wild-type sibling embryos also had better development than those produced by the reciprocal Trp53 þ/À 3 Trp53 þ/þ cross. Further analysis is required to determine the basis for this cell nonautonomous benefit.
Ovulation induction and culture of embryos under limiting conditions favored the formation and development of Trp53 þ/À embryos in vitro, and this shows that this mutation was not recessive for these traits. The observed partial haploinsufficiency illustrates that these conditions can potentially provide a selection pressure that would favor the inheritance of the affected allele. It is becoming widely accepted practice to extend culture of human IVF embryos until the blastocyst stage and to then select the most morphologically advanced for transfer. This study raises the question of whether such practice presents a risk of selecting for mutations that allow or favor embryo development in vitro. Inheritance of reduced TRP53 functionality is an undesirable outcome due to its normal roles (even in the heterozygous state) in guarding the genome from oncogenic damage. The simple media design used here is similar to that used for many assisted reproductive technology programs in the early days; however, it is now common to use more complex media designs. The B6 strain is very sensitive to culture and results in increases in TRP53 in the culture conditions used in this study [12] . It remains to be determined whether this susceptibility reflects the clinical setting, although enhanced expression of TP53 [23] and TP53 accumulation [24] are observed in human embryos produced by IVF using modern techniques.
A range of polymorphisms exist in the human TP53 gene, and some of these seem to be under active selection [25] . The basis of this selection has not been defined. One well-studied polymorphism is at codon 72 of TP53, which may be either arginine (R72) or proline (P72). This polymorphism has functional consequences, with P72 being less efficient at inducing apoptosis than R72. Interestingly, populations of infertile couples have a higher than expected frequency of this P72 polymorphism than expected, and it may play a role in regulating maternal leukemia inhibitory factor production [26] . Polymorphisms in TP53 family genes (P53 [26] , p63, p73 [25] ) and TP53 regulatory genes (Hdm2, Hdm4, and Hausp [25] ) are also significantly enriched in populations of women seeking infertility treatment. The full significance of the large number of naturally occurring TP53 polymorphisms in disease incidence and progression is not yet fully defined [27] .
This study shows that a detailed investigation and understanding of the interactions between TP53 haplotype and gamete and embryo function following assisted reproductive technologies is warranted. The model described here provides a basis for the detailed analysis of whether assisted reproductive technologies create risks of positive selection of deleterious alleles. The effects of other forms of cell stress on gametes and embryos during the peri-conceptual period (such as the metabolic stress associated with maternal diabetes) on the selection of deleterious TP53 haplotypes also warrant such systematic analysis.
